Related references
Note: Only part of the references are listed.High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
Andrew M. Goetze et al.
GLYCOBIOLOGY (2011)
Advances in the assessment and control of the effector functions of therapeutic antibodies
Xu-Rong Jiang et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Naturally occurring glycan forms of human immunoglobulins G1 and G2
Gregory C. Flynn et al.
MOLECULAR IMMUNOLOGY (2010)
Stability of IgG isotypes in serum
Ivan R. Correia
MABS (2010)
The effect of Fc glycan forms on human IgG2 antibody clearance in humans
Xiaoyu Chen et al.
GLYCOBIOLOGY (2009)
Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content
Rodney Keck et al.
BIOLOGICALS (2008)
Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice
Thomas A. Millward et al.
BIOLOGICALS (2008)
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function
Quin Zhou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys
Andrew J. S. Jones et al.
GLYCOBIOLOGY (2007)
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types
Yutaka Kanda et al.
GLYCOBIOLOGY (2007)
Mannose receptor-mediated regulation of serum glycoprotein homeostasis
SJ Lee et al.
SCIENCE (2002)
Share Paper
